![David Crump](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Crump
Geen lopende functies
Loopbaan van David Crump
Eerdere bekende functies van David Crump
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cryptopharma Pty Ltd.
![]() Cryptopharma Pty Ltd. Medical SpecialtiesHealth Technology Cryptopharma Pty Ltd. develops novel anti-inflammatory therapeutic agents for the treatment of pulmonary diseases. It focuses on the development of CP92, a treatment of Cystic Fibrosis. The company was founded by Alastair George Stewart and John Lambert in October 2000 and is headquartered in Victoria, Australia. | President | - | 04-05-2011 |
ZENYTH THERAPEUTICS LIMITED | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Australië | 3 |
Operationeel
President | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cryptopharma Pty Ltd.
![]() Cryptopharma Pty Ltd. Medical SpecialtiesHealth Technology Cryptopharma Pty Ltd. develops novel anti-inflammatory therapeutic agents for the treatment of pulmonary diseases. It focuses on the development of CP92, a treatment of Cystic Fibrosis. The company was founded by Alastair George Stewart and John Lambert in October 2000 and is headquartered in Victoria, Australia. | Health Technology |
CSL Innovation Pty Ltd.
![]() CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
- Beurs
- Insiders
- David Crump
- Ervaring